At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 16:10 ET
Michael J. Farrell, an officer and director of ResMed, filed a Form 144 notice of intent to sell 4,993 shares of common stock with an approximate market value of $1.175 million. The shares were acquired through a stock option exercise on the same day, and the sale is planned for execution on the NYSE.
- Michael J. Farrell (Officer and Director) filed Form 144 to sell 4,993 shares
- Estimated aggregate market value of the proposed sale: $1,175,089.20
- Shares were acquired via stock option exercise on 11/09/2026
- Proposed sale date: 11/09/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access